Current concepts in the management of disseminated intravascular coagulation (Q84340569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Current concepts in the management of disseminated intravascular coagulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

disseminated intravascular coagulation

4 February 2020

main subject

1 reference

Jecko Thachil

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Cheng Hock Toh

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

129 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

S54-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Disseminated intravascular coagulation (DIC): An approach

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Disseminated intravascular coagulation: old disease, new hope

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Current understanding of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Disseminated intravascular coagulation in trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Disseminated intravascular coagulation in infectious disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Expert consensus for the treatment of disseminated intravascular coagulation in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

The diagnosis of disseminated intravascular coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Treatment of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Modified score for disseminated intravascular coagulation in the critically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Substitution of antithrombin III in shock and DIC: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Gabexate as a therapy for disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Treatment of disseminated intravascular coagulation and its prodromal stage with gabaxate mesilate (FOY): a multi-center trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

How I treat acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

High-dose tranexamic acid reduces blood loss in postpartum haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

Disseminated intravascular coagulation in obstetric disorders and its acute haematological management

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

PURPURA FULMINANS. REPORT OF A CASE SUCCESSFULLY TREATED WITH HEPARIN AND HYDROCORTISONE. REVIEW OF 50 CASES FROM THE LITERATURE.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2812%2970017-8

7 January 2021

10.1016/S0049-3848(12)70017-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22682134%20AND%20SRC:MED&resulttype=core&format=json